The pharmacy market in England has seen a significant transformation in recent years, driven by a trend of large-scale disposals by corporate operators.
Jonathan Board, Director - Pharmacy, Christie & Co, has told Pharmacy Business that several corporate operators are looking to sell off their marginal or
non-performing assets while independent operators are eager to acquire and enhance businesses further.
Due to their scale, corporate operators are compelled to adopt a 'one size fits all' approach.
However, Jonathan believes this puts them at a disadvantage compared to many independent operators who are better positioned to meet local patient and
community needs, delivering a more personalised approach to patient engagement, and a variety of other services
"As such, where corporate disposals have taken place, there has been a steady stream of independent operators eager to take over and develop the businesses
further," he said.
The National Pharmacy Association (NPA) has called for immediate intervention by Health Secretary Neil Gray to compensate pharmacies left in financial
chaos due to flaws in Scotland's new pharmacy payment system.
Introduced last year, the system was designed to streamline payments to pharmacies, dispensing doctors, and medical appliance suppliers. However, the NPA, which
represents independent pharmacies across the UK, reported that many pharmacies were facing repeated shortfalls in expected funding under the system.
Some pharmacies have encountered discrepancies of tens of thousands pounds due to errors in the Data Capture Validation & Pricing process introduced by NHS National
Services Scotland.
In other cases, NHS Boards have clawed back money from pharmacies at short notice, following processing errors that had initially resulted in an overpayment.
PAGB, the prominent consumer healthcare association, has appointed a new Vice-President following the departure of Richard Holme from PAGB's Board earlier
this year.
Brian R. Fischel, who currently serves as Regional Director & General Manager for UK and Ireland at Reckitt, is set to take on the new Vice-President role at PAGB.
Bringing extensive international experience as Vice-President at UK trade association representing manufacturers of branded over-the-counter medicines, medical
devices and food supplements, Fischel has over eight years at Reckitt managing various global health territories.
His election in the leadership role in June positions him alongside Bas Vorsteveld, President, and Mike Knowland, Vice President, completing PAGB's executive team.
Michelle Riddalls, CEO of PAGB, expressed optimism about Brian's appointment, emphasising his alignment with PAGB's strategic objectives.
As a medical billing service, it is our primary duty to look after the revenue cycle management process of physicians on board. We are on a mission to narrate billing obligations in a fashion that is fast and in the direct interest of clinicians. Some of our clients have recorded their detailed feedback on Clutch
We present you the motivational journey of Dr. Nadeem Niyaz Jan who has managed to grab the eye-balls of the medical fraternity within the fastest possible time span.
The Royal Pharmaceutical Society (RPS) Assembly has announced the re-appointment of Professor Claire Anderson as President for a further term of two years on
Tuesday (11 July).
As president, Anderson will oversee delivery and implementation of the constitutional governance review; continue to extend the profile and influence of pharmacy
as a profession by building and strengthening relationships with all the other pharmacy leadership bodies and organisations.
She aims to ensure that RPS is invited to the table whenever medicines and public health are discussed by continuing to invest in strategic relationships beyond
pharmacy
Claire was first elected as President in 2021. In her address to the Assembly, Claire said: "This is a time of unprecedented change and I have decided to stand as
President for a second term to offer much needed continuity.
"I am passionate about our profession and committed to making the RPS and our members even more successful. I will also continue to be a dedicated ambassador and
advocate for the profession nationally and internationally."
The lessons from Covid crisis applied in the future through collaboration can create a better integration between GP practices, hospitals and community
pharmacies, Pharmacists Defence Association (PDA) has proposed.
Stating that a more integrated healthcare system could enable pharmacists to provide effective and more efficient care to patients, the PDA proposed a model where
at least two pharmacists would be working in each community pharmacy, empowered, and enabled with two-way referral pathways, having more clinical input and full
access to patient records.
"Such an environment could not only help to improve communications between health professionals and increase access to services for patients, but would support
the NHS to operate more effectively."
Moderna has joined one of the UK's leading pharmaceutical industry body, Association of the British Pharmaceutical Industry (ABPI) to expand its footprint and
investment in the UK.
The biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines will strengthen its footprint with the new state-of-the-art vaccine research,
development and manufacturing facility in the UK. It will create valuable new jobs and build on the strength of the UK's life sciences ecosystem.
The company is best known for their work during the COVID-19 pandemic and are now developing a range of mRNA-based vaccines for a number of conditions.
The ABPI represents companies of all sizes who invest in discovering the medicines of the future, including some of the world's largest, most innovative, and most
successful pharmaceutical firms.
Darius Hughes, UK General Manager, Moderna, said: "We are delighted to join the ABPI - this alliance is an important part of our long-term commitment to the UK and
supports the wider significant investments in manufacturing, research and development we are making in this country.
The Royal Pharmaceutical Society (RPS) Director for Scotland Clare Morrison participated in the panel discussion alongside representatives from other health
professional organisations on tackling the workforce crisis at the SNP conference in Aberdeen on 8 October.
At the conference, the Cabinet Secretary for Health and Social Care committed to achieving protected learning time for health professionals. Morrison welcomed the
Cabinet Secretary's statement as fantastic news for pharmacists across Scotland.
"RPS Scotland will follow up the discussion by writing to the Cabinet Secretary to request a meeting to discuss achieving protected learning time, the forthcoming
results of our workforce wellbeing survey, and positive examples of how pharmacy teams have improved the well-being of their teams," said the society.